phase iii study of veliparib with carboplatin and paclitaxel in her2-negative advanced/metastati...
Published 4 years ago • 129 plays • Length 4:47Download video MP4
Download video MP3
Similar videos
-
3:50
comment: veliparib with carboplatin and paclitaxel in advanced gbrca-positive breast cancers
-
2:59
brocade3: veliparib with carboplatin/paclitaxel in her2-/brca advanced breast cancer
-
25:14
metastatic her2 negative breast cancer: emerging novel treatment strategies
-
3:47
parp inhibitory velaparib trialled in brca1/2 breast cancer
-
1:46
combination of veliparib and chemotherapy in brca-positive breast cancer
-
4:22
veliparib misses pfs endpoint, advances to phase iii trial
-
5:46
adjuvant trastuzumab emtansine vs paclitaxel and trastuzumab for her2-positive breast cancer
-
1:55
rationale for chemotherapy plus veliparib in frontline treatment of ovarian cancers
-
1:17
comment: phase 3 study shows her2 therapy clinically meaningful for metastatic breast cancer pts
-
8:09
olaparib improves disease-free survival in high-risk early-stage her2-negative breast cancer wit...
-
1:25
current state of cdk4/6 inhibitors in metastatic her2-negative breast cancer
-
1:34
is carboplatin an effective addition in the treatment of breast cancer?
-
7:08
selective oestrogen receptor degraders as treatment for er positive/her2 negative advanced/metas...
-
6:13
toripalimab plus metronomic chemotherapy show efficacy in treating in her2-negative metastatic b...
-
1:56
apt: adjuvant paclitaxel and trastuzumab for node-negative, her2 breast cancer
-
8:05
oral paclitaxel yields better outcomes than iv paclitaxel in metastatic breast cancer
-
1:12
results of a phase ii study of palbociclib in esophageal and gastric cancer
-
2:07
recommendations for her2 testing in metastatic breast cancer
-
1:46
phase i/ii study of a novel serca in er her2- bc